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What is an “allergy test”? 1 
 2 
Aiden Foster  aidenpfoster@btinternet.com  3 
 4 
Summary abstract 5 
Allergen specific IgE serology may be used in atopic dogs with well-established all year round 6 
clinical disease as a means of determining potentially significant allergens for inclusion in 7 
immunotherapy. Atopic dermatitis is diagnosed on the basis of appropriate clinical signs and 8 
history and on ruling out other causes of pruritus.  9 
 10 
Serological tests for food and Malassezia allergens are not recommended. Tests may be influenced 11 
by steroid therapy and should not be used as part of an initial diagnostic “work up”. Given that 12 
normal healthy dogs can have IgE antibodies to environmental allergens and atopic dogs may 13 
not, then it is critical to understand and accept that these are not diagnostic tests. Furthermore, 14 
the lack of standardisation and external validation of the allergens, reagents and reporting 15 
methods means that all test results should be interpreted with caution.  16 
 17 
Immunotherapy is helpful in some atopic dogs and can be pursued with motivated owners who 18 
understand the potential value of this safe treatment modality. Given that immunotherapy can 19 
take many months to change the pattern of skin disease observed through the year it is important 20 
to accept that any testing is primarily a direct route to pursuing immunotherapy. Consequently, 21 
such testing (intradermal and serology) may not be suitable for every case of canine atopy and 22 
should only be explored once the pattern of the skin disease has been observed throughout most 23 
of the year in order to appreciate any seasonal variations.  24 
 25 
Introduction 26 
Veterinary clinicians and owners have access to a variety of commercial serological tests that 27 
purport to measure IgE and, in some situations, IgG antibodies, to various allergens. It is clear 28 
from doing referral case work and providing advice to clinicians that there is considerable 29 
confusion about how to use these tests and that there is great potential for misusing these tests 30 
and for wasting clients’ money.  The aim of this article is to provide an overview of how these 31 
tests can be used in dogs; the use of such tests in cats and horses is more complex and the 32 
reader is directed to other sources (Noli and others, 2014).  33 
 34 
When discussing serological methods and atopic dermatitis it has long been emphasised that the 35 
term “allergy test” is potentially misleading; they are not definitive diagnostic tests, they are 36 
meant to aid diagnosis and therapy (DeBoer and Hillier, 2001).  These tests are to be used when 37 
considering a case of canine atopic dermatitis; this disease has well defined historical and clinical 38 
criteria (Hensel and others, 2015); serological (and intradermal) tests are not required to make 39 
a diagnosis. The term allergen test will be used hereafter (short for allergen-specific IgE serology).  40 
Similar constraints also apply to the use of intradermal tests). 41 
 42 
Atopic dermatitis in dogs is usually diagnosed on the basis of an appropriate history and clinical 43 
signs, ruling out ectoparasites and considering the role of cutaneous microbial infections and 44 
assessing for flea, food and contact allergy.  Many healthy normal dogs can have allergen-specific 45 
IgE antibodies; the term subclinical sensitization is sometimes coined when this is reported but 46 
this is potentially misleading because it could be inferred that the dog could be sub clinically 47 
allergic – when in reality normal dogs can have a range of antibodies to antigens in their 48 
environment. Furthermore, substantial numbers of atopic dogs do not have allergen-specific IgE 49 
in their skin or serum – but they still fulfil the criteria for being atopic (the terms “atopic-like 50 
dermatitis” and “intrinsice atopic dermatitis” are sometimes used to describe these dogs).  51 
 52 
Consequently, allergen tests should only be used in dogs well after their skin disease is already 53 
definitively diagnosed as consistent with atopic dermatitis. It is not clinically appropriate to use 54 
such tests when starting to investigate a dog with skin disease (sometimes euphemistically called 55 
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a “full derm work up”); the use of such tests is going to be cost effective only after the case has 56 
been thoroughly investigated  and the disease pattern established.  57 
 58 
Components of an allergen test 59 
 60 
Components of an allergen-specific serological test and their limitations 
Allergen Allergens are commercially prepared for veterinary use; the selection of 
the allergens is based in part on allergens used in studies of human 
allergic conditions and in part on previous positive test results. Allergens 
are extracts and are potentially composed of a large number and wide 
variety of antigenic components.  
 
In human allergy the allergens have been highly characterised. Studies in 
dogs have attempted to characterise some of the environmental allergens 
to which they may be exposed, however, there is limited knowledge at 
present (Mueller and others, 2016).  
 
In laboratory testing the allergen extracts are not standardized, making 
calibration and evaluation of the test results problematic.  
Serum Diluted dog serum is added to the allergen and incubated 
Anti-IgE 
reagent 
Historically it was assumed that this component of the test was unreliable 
because of cross reactivity with the much more common IgG antibodies 
in dog serum. In recent years regents have been shown to be more 
specific and may include monoclonal antibodies and recombinant proteins 
(Fc-epsilon components).  
Signal 
molecule 
This is a reagent that binds to the previous reagent, that has bound to the 
IgE and provides an output that can be measured usually in optical units.  
Reporting 
mechanism 
There are no internationally recognised standard reference units for the 
measurement of IgE; consequently, all tests report arbitrary (relative 
antibody) units that are usually calibrated against results derived from 
(undefined) healthy and allergic cases, and modified by intra-assay 
standards. There are no independent recognised reference standards for 
these assays. There is no external regulation of these tests in terms of 
standardization or calibration or quality control. There are published 
reports of the reproducibility of these tests but that does not tell us 
anything about their reliability or clinical merit in clinical practice.  
 
It is not possible to readily compare results from different laboratories 
because they are potentially using different antigen extracts, assay 
conditions, reagents and reporting systems.  
 61 
Allergens 62 
 63 
Allergen type Comments 
Flea The pathogenesis of flea allergy is presumed to involve a variety of 
immune mechanisms including type 1 hypersensitivity reactions 
associated with IgE; type 4 delayed hypersensitivity reactions may also 
be involved. It is important to appreciate that the detection of 
antibodies to flea allergens does not prove that the dog is allergic – 
healthy normal dogs can also have such antibodies.  
 
Positive test results can be used to support a flea control programme 
and convince the owner that flea exposure has taken place. Negative 
test results do not rule out exposure or the possibility of flea allergic 
dermatitis. 
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Food Considerable efforts have been expended to find a serological test that 
can readily enable a diagnosis of cutaneous adverse food reaction. The 
pathogenesis of “food allergy” remains far from clear and it is unlikely 
to involve IgE alone. 
 
Systematic review of the literature does not support the use of 
serological tests in the diagnosis of food allergy. There is no good 
quality evidence that such tests can help to select a diet for the 
exploration of dietary allergy. Current recommendations are to pursue 
a novel protein-based or hydrolysed diet for at least eight weeks (Olivry 
and others, 2015; Mueller and Olivry 2017).  
Malassezia Atopic dogs will respond to therapy for Malassezia infection with 
improvement in the lesions and the pruritus. This could suggest that in 
some way Malassezia organisms are involved in an allergic process in 
the dog. While intradermal and serological methods have been used to 
detect antibodies to Malassezia extracts their clinical significance is 
unclear. Evidence that dogs may respond to immunotherapy with 
Malassezia extracts is limited at present.  
 
When assessing Malassezia infection it is important to use cytology and 
culture methods to demonstrate the presence of infection and then 
treat accordingly.  
Mites House dust and storage mites are the most important allergen group 
for atopic dogs and such allergens are ubiquitous and difficult to avoid 
in the home environment. Such cases are usually associated with 
pruritus that is present all year round. Some dogs may be worse in the 
summer months because of warmer conditions and higher exposure to 
dust mite allergens.  
Pollens It is often assumed that dogs are allergic to pollens but the pattern of 
skin disease in atopic dogs in the UK is usually not seasonal – making 
it unlikely that pollens are playing a role. Some atopic dogs only show 
signs during the summer months and these cases can be positive on 
testing for pollens, supporting a role for pollen allergy.  
Moulds The evidence that dogs are sensitive to mould allergens is limited.  
When testing a dog with all year round signs of disease it may be the 
case that moulds are clinically important if they come up positive in a 
test.  
Sarcoptes The test for exposure to scabies mites is not strictly an allergen specific 
IgE test because it is usually an IgG ELISA methodology (reviewed by 
Arlian and Morgan, 2017). Some authors believe that the test is useful 
– although like allergen testing there is no external validation of the 
methodology.  
 
Published studies for dogs suggest high specificity and that dogs 
seroconvert in 2-4 weeks after initial exposure. So, a positive test is 
supportive of a diagnosis. However, it could be contended that with 
various licensed products based on macrocyclic lactones and 
isoxazolines, that ruling out scabies in a very pruritic dog is fairly 
straight forward. That is, when you suspect scabies it will not really 
matter what is the test result – the dog ought to be treated to rule out 
scabies (especially when they are very pruritic).  
 64 
Allergen avoidance 65 
It is impossible for atopic dogs to completely avoid the allergens that are causing their skin 66 
disease. Moving a dog indoors may reduce exposure to pollens but there is no evidence that this 67 
is sufficient to control the skin disease alone. Moving a dog outdoors may enable a significant 68 
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reduction in exposure to house dust and storage mites, but most owners cannot keep their pet 69 
completely out of the home. Atopic dogs that seem to improve when placed in kennels, while the 70 
owners are on holiday for several weeks, may have benefitted from reduced mite exposure away 71 
from home.  72 
 73 
Given the propensity for dogs to be sensitised to mites there have been various suggestions for 74 
reducingallergen exposure and some are given below; unfortunately it is highly unlikely that these 75 
measures will have a dramatic impact on the pruritus.  76 
 77 
a) Prevent dust accumulation by removing ‘clutter’ from sleeping areas for example toys, 78 
chews and excess bedding. 79 
b) Keep dogs out of the human bedrooms and away from carpeted areas if possible.  80 
c) Wash bedding regularly (weekly) on a hot cycle. 81 
d) Decrease the temperature of sleeping areas and increase ventilation. 82 
e) Frequent vacuum cleaning and dusting.   83 
Some laboratories recommend using household flea sprays for mite control – this will not be 84 
highly effective alone in controlling mite allergen exposure because the allergen source is still 85 
present in the home (albeit as dead mites(; it may be supportive of other management control 86 
methods (and help to reduce the risk of flea exposure).  87 
Laboratories also recommend feeding wet food for dogs testing positive to storage mites because 88 
these mites have been recorded as present in dry dog food (Hibberson and Vogelnest, 2014)). 89 
There is no substantial benefit from this approach and the positive serology test results merely 90 
reflect exposure and some degree of cross reactivity to house dust mites. Furthermore, the dogs 91 
that test positive will be exposed to much higher mite allergen levels in their home environment 92 
independent of the dry dog food bags.  93 
The key point here is that allergen avoidance is worth pursuing but on its own it is unlikely to 94 
make the atopic dog substantially better. 95 
 96 
Interpretation 97 
Some test results can show multiple positive results which can be confusing and daunting to the 98 
owner and clinician. 99 
 100 
For atopic dogs with non-seasonal, all-year-round disease, a positive result to house dust and 101 
storage mites may well be significant. One factor to take into account is that there may be cross 102 
reactivity to mite allergens and intriguingly discordant results. Many dogs will test highly positive 103 
for the house dust mite Dermatophagoides pteronyssinus (which is assumed to be the 104 
predominant dust mite in the UK); the same dog will often test even higher for D. farinae (which 105 
is not thought to be common in the UK). Even so, such results may still be used for 106 
immunotherapy. Many atopic dogs with positive test results to house dust mites will also test 107 
positive to storage mites; this is likely to be due in part to cross reacting antibodies attaching to 108 
common epitopes in the mite allergen extracts.  109 
 110 
Non-seasonal cases with high test results for pollens are difficult to interpret when there is no 111 
obvious fluctuation in the skin disease during the various phases of the pollen season as tree, 112 
grass and weed pollens are shed from spring to summer (March to September). Some clinicians 113 
assume the results that are positive are significant. Given the large number of dogs that can test 114 
positive to pollens with non-seasonal disease it is potentially more important to focus on the 115 
environmental allergens that are driving the skin disease all year round – mites and possibly 116 
moulds. The pollen antibodies may merely reflect non-specific (or clinically insignificant) 117 
upregulation of the allergic dog’s immune system.  Furthermore, there are reports  of cross 118 
reactive carbohydrate antibodies to protein-linked carbohydrate antigens in dog serum that may, 119 
as in humans, be clinically irrelevant because they lead to false elevation and may confound the 120 
results of serological testing in dogs (Levy & DeBoer 2018).  121 
 122 
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Dogs with only seasonal disease – usually in the pollen months – may only test positive to pollen 123 
– which could be significant. However, such testing is probably not prudent use of client/owner 124 
resources because such testing is mainly performed to pursue immunotherapy; it may be more 125 
cost effective and clinically efficacious to use various other therapies to manage the pruritus 126 
during the months of the dog’s season of disease.  127 
 128 
Influence of steroids 129 
One of the proposed advantages of serological testing is that one does not have to stop steroid 130 
therapy before taking a sample and this is supported in part by a review of the influence of drug 131 
therapies on allergen testing – both intradermal and serological. It has to be stated, however, 132 
that there is limited data on the influence of steroids on allergen-specific IgE serology test results 133 
and the two studies mentioned by Olivry and others (2013) are either an older test method or 134 
only looked at one allergen; furthermore, some companies do believe there is an influence of 135 
steroids on their test system (Wassom and Grieve 1998). Given the substantial number of dogs 136 
that test negative with allergen tests it is prudent to be cautious about the influence of steroids 137 
on the test results and try to avoid long term steroid therapy immediately before a dog is sampled. 138 
The author uses the same wash out periods as those suggested for intradermal testing 139 
(empirically three weeks for oral steroids).  One review reported withdrawal of  oral steroids, such 140 
as (methyl)prednisolone, for two weeks prior to IDT, although the minimum withdrawal time 141 
could not be estimated with certainty  (Olivry and others, 2013).  142 
 143 
Intradermal tests 144 
The intradermal test (IDT) has been used for many years to identify allergens for inclusion in 145 
allergen   immunotherapy (AIT). While familiarity with this method may suggest that this is the 146 
“gold standard method for testing” it has to be acknowledged that the allergen extracts used in 147 
such tests are also not standardised or well characterised. Indeed, studies are still ongoing to try 148 
to establish irritant concentration thresholds to improve the veracity of such tests. The IDT can 149 
be used with allergen serology to potentially identify clinically significant allergens. They are 150 
detecting different types of IgE and are often not well correlated with one another; even so, the 151 
results for either test or when combined can be interpreted in the light of the clinical history.  152 
 153 
Screening tests 154 
Some laboratories offer screening panels where serum is tested against a group of allergens 155 
including various pollen groups and indoor mite allergens. There is no good quality evidence that 156 
these tests are useful in clinical practice – one would only need to use a serum test if intending 157 
to pursue immunotherapy and so the dog will have already been deemed to have met the criteria 158 
for being atopic and so these screens are not diagnostic. They are in reality a tool to promote the 159 
investigation of pruritic dogs and to use serology; they are not recommended.  160 
 161 
Immunotherapy (AIT) 162 
Allergen specific immunotherapy has been recommended for many years for atopic dogs and is 163 
available through several companies (DeBoer 2017; Mueller and others 2017); in the UK there 164 
are no licensed products so an importation certificate from the VMD is required. The success of 165 
immunotherapy is extremely variable and it is likely that many clinicians and owners abandon 166 
this approach at an early stage. Most cases are injected subcutaneously with incremental doses 167 
of allergen and reach a maintenance dose every few weeks. It can take up to 12 months to see 168 
the full impact of immunotherapy and in the interim it is important to intermittently stop other 169 
therapies to see if the immunotherapy is providing some control of the pruritus. There are 170 
protocols for AIT including sublingual and intralymphatic routes of administration.  171 
 172 
Immunotherapy is usually employed in conjunction with a variety of other therapies (oral and 173 
topical) depending upon the nature of the dog’s atopic skin disease. Owners have to understand 174 
and accept that atopic skin disease is a lifelong condition that requires constant regular 175 
intervention with AIT usually forming one part of the control measures for each case.  176 
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 177 
Immunotherapy products are usually based on the results of IDT and / or serology tests. They 178 
are attractive because they are usually extremely safe. Owners can be trained to administer the 179 
injections to their own pets. It is critical to choose clients and pets very carefully for 180 
immunotherapy – owners need to understand how immunotherapy should be used and when to 181 
seek veterinary help when the dog’s skin condition is deteriorating – particularly when there are 182 
flare ups. In some cases immunotherapy can be a very cost effective and safe means of controlling 183 
the signs of atopic dermatitis. 184 
 185 
Atopic skin disease can have variations in the pattern of the clinical signs observed during different 186 
seasons of the year. Consequently, immunotherapy ought to be given over many months, to see 187 
the full impact of such therapy on the pattern of the disease, to include any seasonal variations. 188 
It follows that any allergen testing (intradermal and / or serology) should only be performed long 189 
after the skin condition has started and not as part of an initial investigation when the skin 190 
condition initially becomes apparent. In the case of seasonal problems in the summer then the 191 
testing should be performed in the autumn in order to maximise the chances of identifying 192 
clinically significant allergens. Given the above it should be no surprise that most atopic dogs that 193 
are deemed suitable for testing will be well over one year of age and have had skin disease for 194 
six to 12 months before ANY allergen testing is considered.  195 
 196 
While the pattern of the pruritic skin disease is developing in an atopic dog the owner and 197 
attending clinician can be kept very busy investigating other causes of pruritus including 198 
ectoparasites and pursuing diet trials; various therapies can be trialled to include the management 199 
of secondary microbial infections. These activities can all contribute to the successful management 200 
of an atopic dog. Performing IDT or taking a blood sample for allergen serology should then be 201 
seen as a route to immunotherapy and just one of the various interventions that may be used to 202 
manage atopic dogs. In that regard such testing should only be performed once the pattern of 203 
the skin disease is well established.  204 
 205 
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 254 
 255 
MCQs 256 
 257 
Which allergen group is the most important for atopic dogs? 258 
1 Pollen 259 
2 Moulds 260 
3 Scabies 261 
4 Dust mites 262 
 263 
Allergen serology testing is useful for the management of which allergic skin condition in dogs? 264 
1 Cutaneous adverse food reaction 265 
2 Contact allergy 266 
3 Atopic dermatitis 267 
4 Flea allergy dermatitis 268 
 269 
Allergen serology methods bind to what type of antibody in dog serum? 270 
1 IgG 271 
2 IgE 272 
3 IgA 273 
4 IgM 274 
 275 
Allergen serology test results may be particularly useful in the management of canine atopic 276 
dermatitis using what type of intervention? 277 
1 Allergen avoidance 278 
2 Allergen immunotherapy 279 
3 Identifying breeds at risk of developing skin disease 280 
4 Identifying dogs at risk of developing skin disease 281 
 282 
 283 
